Market research
300519.SHE Zhejiang Xinguang Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- 36.95
- Analyst target
- Not available
- Dividend yield
- 2.1%
- Beta
- 0.3
Community
Investor discussion
1 comment
Sign in to join the 300519.SHE discussion.
5 years, 5 months ago
Zhejiang Xinguang Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 6.0% above its 200 day moving average.
From a valuation standpoint, the stock is 19.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.8.
Zhejiang Xinguang Pharmaceutical Co., Ltd's total revenue rose by 7.7% to $84M since the same quarter in the previous year.
Its net income has increased by 18.5% to $29M since the same quarter in the previous year.
Finally, its free cash flow grew by 2.2% to $27M since the same quarter in the previous year.
Based on the above factors, Zhejiang Xinguang Pharmaceutical Co., Ltd gets an overall score of 5/5.